ASCP

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Retrieved on: 
星期四, 五月 9, 2024
FDA, American Academy, Neurocrine Biosciences, Internet, International, WHO, SCN8A, USAN, Nav1.7, World Health Organization, Safety, NDA, PIN, Food, ASCP, Research, Anhedonia, Depression, Webcast, Information technology, IND, INN, OLE, DSM-IV codes, Patient, Society, Epilepsy, Drug discovery, FOS, SCN1A, Ageing, Pharmaceutical industry

VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.

Key Points: 
  • Successful “end-of-Phase 2” interactions with FDA in MDD; Phase 3 program on track to initiate in the second half of the year
    VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
  • Other income was $11.5 million for the first quarter of 2024, compared to $7.6 million for the same period in 2023.
  • Net loss was $47.9 million for the first quarter of 2024, compared to $41.7 million for the same period in 2023.
  • Xenon will host a conference call and webcast today at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss its first quarter results.

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences

Retrieved on: 
星期四, 五月 9, 2024
Neurology, Mental Health, Health, Pharmaceutical, Clinical Trials, Schizophrenia, CMO, Neuroscience, University of Toronto, University of California, Cognition, Vortioxetine, Biological Psychiatry (journal), Biomarker, Prevalence, Into, Diagnosis, Deficit spending, Drug development, Area studies, Remind, Depression, Data, Pharmacodynamics, EEG, Bipolar, Trial, Chair, Volunteering, Lab, Cognitive deficit, Doctor of Philosophy, Society, University, Cyclothymia, Randomness, ASCP, Pharmaceutical industry

“Alto’s precision psychiatry platform continues to get stronger with each new dataset we analyze.

Key Points: 
  • “Alto’s precision psychiatry platform continues to get stronger with each new dataset we analyze.
  • Importantly, we have systematically identified and prospectively replicated neurobiological markers linked to cognitive impairment associated with schizophrenia in a comprehensive analysis inclusive of all major candidate biomarkers.
  • New analysis of vortioxetine Phase 3 data demonstrates that baseline cognitive performance is not a moderator of response to vortioxetine.
  • A notable relationship between theta response and processing speed, which is thought to underpin cognitive impairment in schizophrenia, was observed.

BYG4lab®, Innovator of Next Generation Software Suites for Laboratories and Diagnostics, Appoints Tim Bickley as VP Sales US to Spearhead Entry into US market

Retrieved on: 
星期三, 四月 10, 2024
Averett University, Society, ASM, Infection, Laboratory, Epidemiology, ASCP, MLS, Medical laboratory scientist, LIS, Health technology, Diagnosis, HIMSS, Patient, Microbiology, Data management, EWC, Health, MBA, Health information management, Medical college, IVD, Medical device

This key executive appointment and expansion marks a significant milestone to introduce the company’s innovative laboratory solutions to the US.

Key Points: 
  • This key executive appointment and expansion marks a significant milestone to introduce the company’s innovative laboratory solutions to the US.
  • BYG4lab is a global software company specializing in clinical laboratory and diagnostic data management solutions.
  • Prior to joining BYG4lab, Tim held VP Sales and Marketing roles at leading laboratory information solution vendors.
  • ASM - American Society for Microbiology, June 13th - 17th, Atlanta, GA.
    ADLM - Association for Diagnostics & Laboratory Management, July 28 - August 1st, Chicago, IL.

ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations

Retrieved on: 
星期三, 四月 24, 2024
Laboratory, ARUP, Hospital, ASCP, EHR, Health care, Electronic health record, Partnership, Workflow, ARUP Laboratories, Patient safety, Health information management, Patient, MBA, Growth

SALT LAKE CITY, April 24, 2024 /PRNewswire/ -- ARUP Laboratories and healthcare connectivity company ELLKAY have forged a new partnership aimed at helping health systems establish or expand successful laboratory outreach operations.

Key Points: 
  • SALT LAKE CITY, April 24, 2024 /PRNewswire/ -- ARUP Laboratories and healthcare connectivity company ELLKAY have forged a new partnership aimed at helping health systems establish or expand successful laboratory outreach operations.
  • "ELLKAY gives health systems the tools to exchange data securely across various systems, including the EHR, registration, payers, the lab, and more."
  • ARUP Healthcare Advisory Services provides expert consultation to health systems seeking to establish or expand laboratory outreach operations.
  • Healthcare consultations include operations assessments, marketing opportunity analyses, and business planning guidance to empower health systems to grow sustainable, profitable outreach operations.

Enable Biosciences Receives Accreditation From The College Of American Pathologists

Retrieved on: 
星期二, 三月 19, 2024
College, Risk, Patient, SAN, Accreditation, CAP, Laboratory, MD, Carolyn Bertozzi, ASCP, DPH, Health

SOUTH SAN FRANCISCO, Calif., March 19, 2024 /PRNewswire/ -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Enable Biosciences Clinical Reference Laboratory in South San Francisco, California, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 19, 2024 /PRNewswire/ -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Enable Biosciences Clinical Reference Laboratory in South San Francisco, California, based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.
  • Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes.
  • Enable Biosciences is now among more than 8,000 CAP-accredited facilities worldwide.
  • "This accreditation underscores our commitment to providing the highest quality diagnostic services," said Lynette Sawyer, reflecting on the achievement.

Data Innovations Releases Lab GPS v2.1

Retrieved on: 
星期三, 二月 14, 2024
SSO, Google Play, Lab, IOS, App Store (iOS/iPadOS), ASCP, Apple Store, Instrument, Software as a service, Android, Health, LIS, Environment, Medical device

COLCHESTER, Vt., Feb. 14, 2024 /PRNewswire/ -- Data Innovations announces the availability of Lab GPS™ v2.1., which introduces a new mobile app and other enhancements to enterprise lab uptime monitoring and optimization through its truly vendor-neutral connectivity platform, Instrument Manager™ (IM). Lab GPS helps minimize costly clinical laboratory downtime and improve patient care by empowering laboratorians and IT administrators with all-in-one connectivity monitoring, notifications, and control.

Key Points: 
  • In this further development of Data Innovations' first cloud-hosted SaaS product, Lab GPS v2.1 enables LIS administrators to resolve connectivity issues faster by viewing and acting on issues from a mobile device.
  • Among the features of Lab GPS v2.1:
    As with the desktop version of Lab GPS, the mobile app allows LIS administrators to restart LIS and instrument connections remotely, thereby reducing lab downtime and improving patient care.
  • Lab GPS is only available to direct Data Innovations customers in the United States using Instrument Manager™ and is not available on business partner-sold systems.
  • More information on Lab GPS, including the ability to schedule a demo, can be found by clicking here .

KLAS Research Names Relatient Best in KLAS for Patient Self-scheduling

Retrieved on: 
星期三, 二月 7, 2024
Software, Practice Management, Telemedicine, Virtual Medicine, Health, Data Management, Health Technology, Technology, Other Health, ASCP, Feedback, MLS, Research, Patient, Dash, Plague, Health informatics, MBA, Tiffany Cross, Covenant Health, Organization, Retail

1 Best in KLAS patient self-scheduling solution by KLAS Research.

Key Points: 
  • 1 Best in KLAS patient self-scheduling solution by KLAS Research.
  • The Best in KLAS rankings are a direct result of feedback from thousands of providers throughout 2023.
  • 2024 marks the first year that KLAS has included the category of Patient Self-Scheduling in its rankings.
  • We’re thrilled to achieve this honor.”
    The Best in KLAS report is an annual award program recognizing software and service companies that excel in helping healthcare professionals improve patient care.

Midwest Transplant Network Surpasses Expectations to Save and Enhance Lives in 2023

Retrieved on: 
星期一, 二月 5, 2024
Partnership, Haematopoietic system, CCRN, DCU, ACHI, ASCP, Hospital, Patient, Transplant, MSN, Overmyer Network, OPO, Urinalysis, Hope, MTN, Eye, RN, Operating, Dentistry

“What we achieved at Midwest Transplant Network in 2023 reflects the commitment of the staff who do the work every day to support organ donation and transplantation.

Key Points: 
  • “What we achieved at Midwest Transplant Network in 2023 reflects the commitment of the staff who do the work every day to support organ donation and transplantation.
  • The work is hard, and happens in countless ways, but we are all dedicated to the mission of enhancing and saving lives through organ, eye and tissue donation” said Jan Finn, RN, MSN, President & CEO, Midwest Transplant Network.
  • The United Network for Organ Sharing reported that across the country, clinical workers performed more than 46,000 lifesaving transplants in 2023.
  • Incorporated in 1973, Midwest Transplant Network facilitates organ, eye and tissue donation in partnership with hospitals and other professional partners to give hope and share life.

Sharon Ward-Fore, MS, BS, MT(ASCP), CIC, FAPIC, honored with the Infection Control Today Educator of the Year Award™

Retrieved on: 
星期二, 十二月 19, 2023
Online, Biology, Workforce, Multimedia, Microbiology, Infection, ASCP, Research, Disinfectant, ICT, IPS, Education, Heart, APIC, Love, CIC, IP, Nursing

Additionally, the individual must have done a superlative job in educating internal and external stakeholders about the importance of infection prevention.

Key Points: 
  • Additionally, the individual must have done a superlative job in educating internal and external stakeholders about the importance of infection prevention.
  • She started her career in an acute care hospital microbiology lab, then transitioned to industrial microbiology research and development.
  • Ward-Fore is an independent infection prevention consultant, a member of the editorial advisory board of the Infection Control Today journal, and a clinical editor for APIC Text Online.
  • Ward-Fore has a Bachelor of Science degree in biology and medical technology, a Master of Science degree in clinical microbiology, and is board-certified in infection control (CIC).

JP Kotha Appointed Vice President, Bioanalytical at Worldwide Clinical Trials

Retrieved on: 
星期三, 十一月 29, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Foot, ASCP, Hematology, Patient, Multimedia, Worldwide, Automation, Therapy, Fine chemical, BioAnalyt, MBBS

Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has appointed Jayaprakash (JP) Kotha , MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical.

Key Points: 
  • Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has appointed Jayaprakash (JP) Kotha , MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical.
  • Kotha now leads lab operations and all activities in Worldwide’s Bioanalytical Center of Excellence , located in Austin, Texas.
  • View the full release here: https://www.businesswire.com/news/home/20231129451629/en/
    Worldwide Clinical Trials appoints Jayaprakash (JP) Kotha, MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical.
  • “Worldwide is known for its specialized approach to bioanalytical services and clinical trials – one that prioritizes personalized partnerships and accessible technical expertise for its customers.